Abstract: Methods, systems, and apparatuses for device routing management are disclosed. A client device of a wireless network may roam from a first access point to a second access point of the wireless network. The second access point, or the client device itself, may send a network message indicating the client device is currently being served by the second access point. The message may cause a network mapping stored at the first access point and/or at each device associated with the wireless network to be updated to indicate the client device is associated with the second access point, thereby enabling proper routing of network traffic to the client device via the second access point.

Abstract: Methods, systems, and apparatuses for device routing management are disclosed. A client device of a wireless network may roam from a first access point to a second access point of the wireless network. The second access point, or the client device itself, may send a network message indicating the client device is currently being served by the second access point. The message may cause a network mapping stored at the first access point and/or at each device associated with the wireless network to be updated to indicate the client device is associated with the second access point, thereby enabling proper routing of network traffic to the client device via the second access point.

Abstract: Methods, systems, and apparatuses for device routing management are disclosed. A client device of a wireless network may roam from a first access point to a second access point of the wireless network. The second access point, or the client device itself, may send a network message indicating the client device is currently being served by the second access point. The message may cause a network mapping stored at the first access point and/or at each device associated with the wireless network to be updated to indicate the client device is associated with the second access point, thereby enabling proper routing of network traffic to the client device via the second access point.

Abstract: The present invention relates to an industrially feasible and economically viable process for preparation of SGLT2 inhibitors of formula X in significantly high yield and purity.

Abstract: Methods, systems, and apparatuses for device routing management are disclosed. A client device of a wireless network may roam from a first access point to a second access point of the wireless network. The second access point, or the client device itself, may send a network message indicating the client device is currently being served by the second access point. The message may cause a network mapping stored at the first access point and/or at each device associated with the wireless network to be updated to indicate the client device is associated with the second access point, thereby enabling proper routing of network traffic to the client device via the second access point.

Abstract: The present invention relates to an industrially feasible and economically viable process for preparation of Bexagliflozin of formula V in significantly high yield and purity.

Abstract: The present invention relates to an industrially feasible and economically viable process for preparation of SGLT2 inhibitors of formula X in significantly high yield and purity.

Abstract: The present invention relates to a novel crystalline polymorphic form of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine hydrochloride; commonly known as vortioxetine hydrochloride (hereafter referred to as the compound (Ia) and process for its preparation comprising of treating the compound (Ia) (as described herein) with a ketone solvent or mixture of ketone solvent with other solvents. The present invention also relates to an improved process for the preparation of vortioxetine hydrobromide (Ia), comprising reacting the compound (I) (as described herein) with hydrogen bromide solution in acetic acid.

Abstract: Methods, systems, and apparatuses for device routing management are disclosed. A client device of a wireless network may roam from a first access point to a second access point of the wireless network. The second access point, or the client device itself, may send a network message indicating the client device is currently being served by the second access point. The message may cause a network mapping stored at the first access point and/or at each device associated with the wireless network to be updated to indicate the client device is associated with the second access point, thereby enabling proper routing of network traffic to the client device via the second access point.

Abstract: A device such as a mobile device may be configured to connect to and/or communicate with one or more networks. The device may receive information indicating that there is at least one other network within a range of the device. One of the networks within range of the device may comprise a preferred cellular network. The device may then scan for the preferred cellular network and communicate with the preferred cellular network. The device may also detect the preferred cellular network based on information stored on the device. When the device is within range of the preferred cellular network, the device may detect the preferred cellular network based on the stored information and begin communicating with the preferred cellular network.

Abstract: The present invention relates to an industrially feasible and economically viable process for preparation of Bexagliflozin of formula V in significantly high yield and purity.

Abstract: The present invention provides an improved process for preparation of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine; commonly known as vortioxetine (referred to as the compound (I)) and pharmaceutically acceptable salts thereof; wherein the process comprises reaction of 2-((2,4-dimethylphenyl)thio)aniline (II) with bis(2-alkyl)amine (IIIa) or its salt in the presence of a cyclic amide solvent.

Abstract: The present invention provides an improved process for preparation of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine; commonly known as vortioxetine (referred to as the compound (I)) and pharmaceutically acceptable salts thereof; wherein the process comprises reaction of 2-((2,4-dimethylphenyl)thio)aniline (II) with bis(2-alkyl)amine (IIIa) or its salt in the presence of a cyclic amide solvent.

Abstract: The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form.

Abstract: The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form.

Abstract: The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form.

Abstract: A method includes obtaining a model associated with production of natural gas from a well, where the well has a choke valve that controls flow of material including natural gas from the well. The method also includes identifying, using the model, a solution that increases an amount of natural gas obtained from the well over a specified time horizon. In addition, the method includes adjusting operation of the choke valve based on the identified solution. The model could be generated using geological data associated with the well and/or historical data associated with natural gas production from the well. A natural gas reservoir can be modeled as a continuous stirred bed with a rock or shale void fraction using mass or volumetric unit balances. Gas content versus pressure for the well can be plotted, and Langmuir adsorption parameters for the well can be identified using the plotted gas content versus pressure.

Abstract: The invention relates to a topical pharmaceutical composition for burn treatment and microbial infections on human beings or animals. The pharmaceutical composition comprises 0.1% w/w to 1.0% w/w of an antimicrobial drug, i.e., silver sulfadiazine and 0.2% w/w antiseptic, i.e., chlorhexidine gluconate, wherein silver sulfadiazine is in nanonized form.

Abstract: Disclosed herein is a system and method for creating and delivering integrated advertisements. An integrated advertisement may include a markup language portion for defining various formatting and properties of an advertisement and an image portion containing a plurality of images. Each of the images in the image portion may be designed to correspond with a particular screen size. The integrated advertisement provides scalability for delivering the advertisement to a number of different devices in accordance with multiple targeting criteria. The integrated advertisement also enables efficient management and reporting of advertising campaigns. An advertisement server selects and delivers an integrated advertisement and dynamically binds the markup language portion with one of the plurality of images based on the screen size of the device requesting the advertisement.

Abstract: A system includes a controller and an apparatus that includes a housing having a volume and an inlet. The inlet can receive a fluid that includes a gas and a liquid. The apparatus also includes a baffle that partitions the volume into a first portion and a second portion. The baffle extends from a base of the housing. The first portion can receive the liquid and separate the liquid into a first part and a second part. The second portion can receive the second part of the liquid from the first portion. The controller regulates an amount of the second part of the liquid in the second portion such that a level of the second part of the liquid is higher than a height that the baffle extends from the base of the housing, thus enabling the use of the extra surge capacity in the vessel.